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Peripheral endothelial cells are capable of erythrophagocytosis, but data on
brain endothelial erythrophagocytosis are limited. We studied the relationship
between brain endothelial erythrophagocytosis and cerebral microhemorrhage, the
pathological substrate of MRI-demonstrable cerebral microbleeds. To demonstrate
the erythrophagocytic capability of the brain endothelium, we studied the interactions
between brain endothelial cells and red blood cells exposed to oxidative stress
in vitro, and developed a new in vitro cerebral microbleeds model to study the
subsequent passage of hemoglobin across the brain endothelial monolayer. Using
multiple approaches, our results show marked brain endothelial erythrophagocytosis
of red blood cells exposed to oxidative stress compared with control red blood cells
in vitro. This brain endothelial erythrophagocytosis was accompanied by passage of
hemoglobin across the brain endothelial monolayer with unaltered monolayer integrity. In
vivo and confocal fluorescence microscopy studies confirmed the extravasation of RBC
exposed to oxidative stress across brain endothelium. These findings, demonstrating
erythrophagocytosis mediated by the brain endothelial monolayer and the subsequent
passage of iron-rich hemoglobin in vitro and RBC in vivo, may have implications for
elucidating mechanisms involved in the development of cerebral microbleeds that are
not dependent on disruption of the microvasculature.
Keywords: erythrophagocytosis, cerebral microbleeds, brain endothelial cells, hemoglobin, red blood cells,
transmigration
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INTRODUCTION

saline (PBS) or tert-butylhydroperoxide (t-BHP), an oxidative
stressor that results in the exposure of RBC phosphatidylserine
(PS) to mimic aged and/or injured RBC marked for phagocytic
removal from the circulation (Schroit et al., 1985). Using multiple
approaches, our results show robust adhesion and engulfment
(erythrophagocytosis) of t-BHP-RBC by brain endothelial cells
(bEND3) compared with PBS-RBC. We developed a new CMB
in vitro model system to study passage of RBC degradation
product hemoglobin across bEND3 cells, and show passage
of hemoglobin from t-BHP-treated RBC across the bEND3
monolayer with unaltered monolayer integrity. Our in vitro
results were corroborated by our in vivo findings of extrusion of
fluorescently-labeled RBC across the mouse brain endothelium.
These results may have important implications for elucidating
mechanisms involved in the development of CMB demonstrated
on brain MRI.

Cerebral microhemorrhages are tiny deposits of blood
degradation products in the brain and are the pathological
substrate of cerebral microbleeds (CMB). CMB are associated
with increasing age, cerebrovascular diseases, hypertension,
and chronic kidney disease (Lau et al., 2017). Mechanistically,
it is widely accepted that loss of vascular integrity due to
an underlying disruption of the cerebral microvasculature
causes CMB development, and these are classified as primary
microbleeds (Fisher, 2014). Other mechanisms involved in CMB
development include hemorrhagic infarction/microinfarction,
and these are classified as secondary microbleeds (Fisher, 2013,
2014). Besides the involvement of hemorrhagic and ischemic
processes in the development of CMB, there has been some
indication that release of iron from oligodendrocytes during
ischemia may result in MRI-demonstrable CMB (Janaway
et al., 2014). Further, the existence of pseudo-microbleeds, a
phenomenon in which iron-rich hemosiderin from red blood
cells (RBC) produces signatures of CMB in the absence of
vascular disruption, has been proposed (Fisher, 2014).
A recent study showed that brain endothelium have
phagocytic properties and that brain vascular endothelial cells
are capable of engulfing and translocating intracranial emboli
into the brain extravascular space, a process termed angiophagy
(Grutzendler et al., 2014). The concept of angiophagy has
some similarities to endothelial erythrophagocytosis, a recently
described process by which injured or aged erythrocytes are
ingested by endothelial cells, undergo hemolysis, and are cleared
from the blood circulation (Fens et al., 2010). Endothelial
erythrophagocytosis has recently been reported by peripheral
endothelial cells using human umbilical vein endothelial
(HUVEC) and hepatic sinusoidal endothelial cells in vitro, and
has further been confirmed in vivo (Fens et al., 2010, 2012; Lee
et al., 2011).
In
the
cerebral
milieu,
macrophage-mediated
erythrophagocytosis has been well-documented (Zhao et al.,
2009), and the involvement of macrophages in CMB is known
(Fisher et al., 2010). Besides macrophages, pericytes are known to
have phagocytic function and there is some evidence of pericyte
mediated erythrophagocytosis in the brain (Fisher et al., 2010).
Phagocytosis of parasitized RBC by brain endothelium within
an inflammatory milieu has been reported in in vitro studies
of cerebral malaria (Jambou et al., 2010). Involvement of brain
endothelium in phagocytosis of non-parasitized aged and/or
injured RBC and subsequent transmigration of RBC or RBC
degradation products (hemoglobin) into the brain has not been
reported. It has been proposed that iron-rich extravasated RBC
or RBC degradation products may produce MRI signatures of
CMB in the absence of vascular disruption (pseudo-microbleeds)
(Fisher, 2014).
The above prompted us to investigate the role of the
brain endothelium in mediating erythrophagocytosis of aged
and/or injured RBC, and subsequent passage of RBC and/or
RBC degradation product hemoglobin into the brain. In the
current proof-of-concept study to demonstrate brain endothelial
erythrophagocytosis, RBC were treated with phosphate buffer
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MATERIALS AND METHODS
Red Blood Cell Preparation and Treatment
Purified RBC in Alsevers solution were derived from 2 to
3 month-old male BALB/c mice (BioReclamation IVT, New
York, NY). RBC were washed and resuspended in sterile
PBS (without Ca2+ and Mg2+ ) before experimental treatment
with PBS (control; incubation time: 30 min), lipopolysaccharide
derived from gram negative bacterium Salmonella Typhimurium
(LPS, 10 µg/mL; incubation time: 1 h; an inflammatory stimulus),
neuraminidase enzyme from vibrio cholerae (0.125 U or 0.5 U;
incubation time: 1 h; for senescence induction) or various
concentrations (0.3, 1.0, 3.0 mM) of t-BHP (incubation time:
30 min; an oxidative stressor) at 37◦ C. LPS, neuraminidase, and tBHP were selected for the current study based on previous studies
using peripheral endothelial cells (Tissot Van Patot et al., 1996;
Fens et al., 2012; Yang et al., 2014). After treatment, RBC were
washed and resuspended in sterile PBS to desired concentrations
described below. All the above materials were purchased from
Sigma-Aldrich, St. Louis, MO.

Brain Endothelial Cell Culture
Murine brain microvascular endothelial cells (bEND3 cells;
American Type Culture Collection, Manassas, VA) between
passages 22 and 31 were grown on T75 flasks in Delbucco’s
Modified Eagle’s Medium (DMEM) containing 0.45% glucose,
0.37% NaHCO3 , 4 mM Glutamine, 10% fetal bovine serum, and
100 µg/ml penicillin/streptomycin (Sigma, St. Louis, MO). After
reaching 70–80% confluency, cells were subcultured in complete
DMEM and seeded onto 6-well plates (5 × 105 bEND3 cells per
well), 24 well plates with 0.2% gelatin coated glass cover slips (1 ×
105 bEND3 cells per coverslip), or 12-well transwells with 3 µm
pore polyester membrane inserts with a surface area of 1.12 cm2
(Corning, New York, NY) (1 × 105 bEND3 cells per well). For
all the experiments, 5 × 106 treated RBC were incubated with the
seeded bEND3 cells for up to 24 h at 37◦ C in 5% CO2 . For initial
experiments, 24 h after initial seeding of bEND3 cells grown on
24 well plates with 0.2% gelatin coated cover glass, bEND3 cells
were primed with or without 100 ng/mL of LPS for another 24 h
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extent of erythrophagocytosis. The amount of hemoglobin was
expressed as % of hemoglobin detected with the bEND3 only
group. Published studies have shown that high concentrations of
t-BHP convert hemoglobin to methemoglobin (Murakami and
Mawatari, 2003), which is not detected by the DAF assay. This
was further confirmed in our lab (data not shown) and as a result,
the DAF assay was performed using the lowest dose of t-BHP
(0.3 mM).

before being incubated with treated RBC to determine the effect
of endothelial activation on RBC-bEND3 interactions.

Annexin V-FITC Labeling
To quantify the percentage of treated RBC with PS exposure,
t-BHP- and PBS-treated RBC were labeled with annexin-VFITC (BioLegend, San Diego, CA) as per the manufacturer’s
instructions. Briefly, after wash and resuspension of RBC in
sterile PBS, 1 × 106 RBC were incubated in FITC-labeled
annexin-V and 1.2 mM Ca2+ for 30 min in the dark. After
washing and resuspending in sterile PBS, RBC were quantified
with a flow cytometer (Accuri C6 Plus, BD, Franklin lakes,
NJ) using logarithmic gain for light scatter and fluorescence
channels with gating and background settings defined through
the PBS/control RBC.

Red Blood Cell Incubation Viability
The viability of PBS- and t-BHP-treated RBC in cell culture
incubation environment was assessed by incubating treated RBC
(5 × 106 cells per well) in DMEM or FBS-free DMEM into 24
well plates. After 24 h, 10 µL cells were collected and mixed with
trypan blue at 1:1, and manually counted with a hemocytometer
for both live and dead RBC based on trypan blue exclusion.
Viable RBC were expressed as % of total RBC.

Hematoxylin and Eosin Staining
Twenty-four hours after initial bEND3 seeding on 0.2% gelatin
coated glass coverslips in 24 well plates, the cells were incubated
with RBC treated either with PBS or t-BHP for 3 h, 18 h and
24 h. Glass cover-slips were then fixed with 4% paraformaldehyde
(PFA) for 15 min on ice followed by hematoxylin and eosin
(H&E) staining. Briefly, each coverslip was washed with ice cold
PBS, stained with hematoxylin for 10 min followed by Scott’s Tap
Water wash, stained with eosin Y for 8 min, and washed with
ethanol and dipped in xylene before mounting. Six fields of view
per coverslip were manually quantified by an observer blinded
to the treatment using light microscopy at a 20X magnification
to estimate: RBC adhesion: RBC to bEND3 ratio (expressed as
%) and engulfment: % of bEND3 that were positive for RBC
engulfment.

Confocal Microscopy
Brain endothelial cell tight-junctions were imaged and analyzed
through Zonula Occludens-1 (ZO-1) staining and confocal
microscopy. Twenty-four hours after initial bEND3 seeding
on 0.2% gelatin coated glass coverslips in 24 well plates,
the cells were incubated with RBC treated either with PBS
or t-BHP for 24 h. Glass cover-slips were then fixed with
2% PFA, blocked in 5% bovine serum albumin (BSA) in
PBS with 0.1% tritonX-100, incubated with ZO-1 antibody
(1:100, ZO-1 Alexa Flour 488, SantaCruz Biotechnology,
Dallas, TX; Antibody Registry Accession No. AB_628459)
in PBS with 0.75% BSA overnight at 4◦ C, followed by
endothelial nuclear staining with DRAQ5 (BioLegend, San
Diego, CA). Cover-slips were mounted with VectaShield
Hardset Mounting Medium (Vector Labs, Burlingame, CA) and
imaged with a Leica SP5 confocal microscope (Leica, Wetzlar,
Germany).

Diaminofluorene Assay
H&E staining results were confirmed using a colorimetric
assay which is based on the pseudoperoxidase activity of
hemoglobin using 2,7-diaminofluorene (DAF) (Sigma, St. Louis,
MO) substrate and hydrogen peroxide (Gebran et al., 1992). For
this, bEND3 cells seeded onto 6-well plates at 5 × 105 cells
per well for 72 h at 37◦ C in 5% CO2 were used. After 72 h,
cell media was changed from the FBS-supplemented DMEM
to strictly FBS-free DMEM. After media change, RBC treated
with PBS or t-BHP were incubated with the bEND3 cells for
24 h. bEND3 cells without RBC served as control (bEND3
only group). After incubation, the supernatant media of the
wells was aspirated, wells were washed with distilled water to
lyse attached RBC (RBC that are not engulfed by endothelial
cells) and incubated with 0.2M Tris-HCl buffer containing 6M
urea lysis solution for 30 min, followed by circular scrubbing
with cell scrappers to further lyse bEND3 cells to release
hemoglobin. DAF dye stock solution (10 mg/mL in 90% acetic
acid) was added to 10 mL of 6M urea with 100 µL of hydrogen
peroxide to make a DAF working solution which was used to
react with 100 µL of supernatant of each well prepared above
and immediately read on a SpectraMax 384 microplate reader
(Molecular Devices, Sunnyvale, CA) at 620 nm. A hemoglobin
standard (Lee Biosolutions, Maryland Heights, MO) was used to
estimate the amount of hemoglobin which is an indicator of the
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Live Imaging
To visualize the time-lapse of events that occurs between bEND3
cells and RBC, PBS- and t-BHP-treated RBC that were incubated
with bEND3 cells on 6-well plates were placed in an incubator
(37◦ C in 5% CO2 ) with LumaScope 720 imaging microscope
(EtaLuma, Carlsbad, CA) that captured images of each well every
2.5 min over a course of 24 h. The timestamped images were then
compiled into an mpeg file that illustrated the time-lapse at 3
frames per second.

Transmigration of Hemoglobin Across the
bEND3 Monolayer
To determine the appropriate time to initiate the transmigration
experiments, the integrity of the bEND3 monolayer in the
transwells was assessed by performing transendothelial electrical
resistance (TEER) measurements using the EVOM2 Epithelial
Volt/Ohm Meter and an STX-2 electrode system (World
Precision Instruments LLC, Sarasota, FL) at various time points
(3, 24, 48, and 72 h) in each well.
The experimental setup of the transmigration experiment is
shown in Figure 4A. To assess whether hemoglobin from treated
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Measurement of Free Hemoglobin From
RBC

RBC migrates through the endothelial monolayer, bEND3 cells
were cultured onto the apical wells of the transwells with
complete DMEM for 72 h (time at which maximum TEER
was obtained; data not shown), followed by replacement of
the complete DMEM with FBS-free DMEM. PBS- and t-BHPtreated RBC were then added to the apical wells, incubated
undisturbed for 24 h at 37◦ C in 5% CO2 . Endothelial cells grown
on transwell inserts without RBC served as controls (bEND3
only group). After incubation, media in the basolateral well was
gently mixed and 200 µL of the media was collected and lysed
with 200 µL of 0.2 M Tris-HCl buffer containing 6 M urea for
15 min at RT. The basolateral aliquot was then examined for
hemoglobin passage across the bEND3 monolayer using the
DAF and hemoglobin standard assay described above. Passage of
hemoglobin across bEND3 monolayer-free transwell insert was
used to assess spontaneous migration of hemoglobin across the
transwell insert. Hemoglobin amount was expressed as % bEND3
only group (control).
TEER measurements were performed in triplicates per insert
before addition of RBC to the apical well (0 h) and 24 h
after RBC incubation to assess monolayer integrity during the
transmigration experiment. All TEER values were corrected
for the blank TEER of monolayer-free transwell inserts and
represented at % PBS RBC values.

bEND3 cells (1 × 105 ) seeded onto 24 well plates were allowed
to grow to confluence and incubated with PBS- or t-BHPtreated RBC in FBS free media for 3 h, 18 h, and 24 h. At
the predetermined time intervals, media was collected from
each well, and placed in Amicon-100K centrifuge tubes (Fisher
Scientific, Hampton, NH). After spinning for 10 min at 14,000
RPM, the filtrate at the bottom containing the free hemoglobin
was collected (RBC are retained on top) and processed using the
DAF assay described above to determine free hemoglobin present
in the media represented as % of hemoglobin from PBS RBC (%
control).

Statistical Analysis
All statistical analysis was performed using GraphPad Prism 5
(GraphPad Software Inc., La Jolla, CA). Data are presented as
mean ± SEM of at least 3 independent experiments done in
duplicates based on power analysis which indicated that at least 3
experiments will be needed to detect a difference of 20% between
groups with a power of 80% and significance level of 5%. To
compare more than 2 independent groups, one-way ANOVA
with Bonferroni’s correction was used. For data with more than
2 independent groups and 2 independent variables, two-way
ANOVA, with or without repeated measures, was used. A twotailed p < 0.05 for the entire family of comparison was considered
statistically significant.

In vivo Passage of RBC Across the Brain
Endothelium
All animal procedures were approved by UCI Institutional
Animal Care and Use Committee and were carried out in
compliance with University Laboratory Animal Resources
regulations. Passage of t-BHP-treated RBC across the brain
endothelium was visualized using postmortem confocal
fluorescence microscopy. Adult male Tie2-GFP mice (10–12
week old, Jackson Laboratory, Bar Harbor, ME) with green
fluorescent protein (GFP) labeled endothelial cells were used for
imaging. Briefly, autologous blood (200–250 µL) was collected
from Tie2-GFP mice (n = 2) and RBC were purified using
Ficoll-Paque (GE Healthcare, Uppsala, Sweden) gradient. After
several washes in PBS, RBC were treated with PBS or 3 mM
t-BHP for 30 min at 37◦ C as described above and stained with
PKH-26 Red Fluorescent Cell Linker Kit (Sigma, St. Louis,
MO) according to manufacturer’s instructions and re-injected
into the mice intravenously. Mice were euthanized 24 h after
RBC injection using a lethal dose of Euthasol (150 mg/kg, i.p.)
and whole brains were harvested for postmortem confocal
fluorescence microscopy to visualize passage of RBC across the
brain endothelium.
Fluorescence images of whole brains were obtained using
Zeiss LSM 510 microscopy system equipped with a longworking
distance Zeiss 40x, 0.8 NA water immersion objective. Laser
scanning did not induce any visible damage to the tissue or
noticeable bleaching of the sample. Stacks of images were
acquired with the z-step (distance between consecutive imaging
planes) of 2.5 µm. The maximum depth for imaging was up
to 80 µm from the brain surface. The probed 3D volume was
reconstructed by Zeiss LSM original software.

Frontiers in Cellular Neuroscience | www.frontiersin.org

RESULTS
Three-hour incubation of PBS-treated bEND3 cells with PBStreated RBC resulted in negligible RBC adhesion to bEND3 cells.
There was a significant (p < 0.001) increase in the adhesion of
3 mM t-BHP-treated RBC to PBS-treated bEND3 cells compared
with PBS-treated RBC incubated with PBS-treated bEND3 cells
(Figure 1A). Treatment of RBC with LPS or neuraminidase
(0.125U or 0.5U) did not significantly alter RBC adhesion to PBStreated bEND3 cells compared with PBS-treated RBC incubated
with PBS-treated bEND3 cells (Figure 1A). Treatment of the
bEND3 cells with LPS did not have a significant effect on
RBC adhesion under any condition tested in the current study
(Figure 1A) or with an increase in incubation time (data not
shown).

Phosphatidylserine Exposure
Studies with annexin-V FITC showed that greater than 90% of
t-BHP-treated RBC are annexin-V FITC positive confirming PS
exposure on the surface of t-BHP-treated RBC compared with
PBS-treated RBC (Figure 1B).

Concentration and Time Dependent
RBC-bEND3 Erythrophagocytosis
(Adhesion and Engulfment)
RBC treatment with low and medium concentrations of t-BHP
(0.3 and 1 mM) resulted in negligible RBC adhesion to the
bEND3 cells following 3 h incubation. RBC treatment with high

4

September 2018 | Volume 12 | Article 279

Chang et al.

Brain Endothelial Erythrophagocytosis and Cerebral Microbleeds

FIGURE 1 | RBC adhesion to brain endothelial (bEND3 cells) under different conditions (A) and PS exposure in t-BHP-treated RBC (B). RBC treated with PBS
(control), LPS (10 µg/mL) or neuraminidase (0.125 U or 0.5 U) did not significantly alter RBC adhesion to bEND3 cells following 3 h incubation, however, 3 mM t-BHP
treatment of RBC resulted in a significant increase in RBC adhesion to bEND3 cells compared with respective PBS-treated RBC. LPS treatment of bEND3 cells did
not further enhance RBC adhesion under any treatment conditions. >90% of 0.3 mM t-BHP-treated RBC were PS positive compared with PBS-treated RBC as
determined by flow cytometry (B). Data is presented as mean ± SEM of at least 3 independent experiments. ***p < 0.001.

compared with the control and PBS-treated RBC, confirming the
light microscopy results (Figure 2F).
Adhesion and engulfment of t-BHP-treated RBC by
the bEND3 monolayer was further confirmed using live
cell time-lapse imaging (see Supplementary Video 1),
immunofluorescence and confocal microscopy. Figure 3A
shows a maximum projection of a 6 µm depth z-stack image
with a step size of 0.3 µm, and confirms the presence of tight
junction protein ZO-1 in the confluent bEND3 monolayer (ZO-1
tight junction protein staining shown in green and bEND3 nuclei
stained with DRAQ5 shown in blue). Both PBS- and t-BHPRBC autofluoresce (green) as shown in the figure. Adhesion
and engulfment of t-BHP-treated RBC is further confirmed by
orthogonal and single z-stack projections (Figure 3B).

concentration of t-BHP on the other hand resulted in significant
RBC adhesion to the bEND3 cells as early as following 3 h
incubation. Overall, adhesion of t-BHP-treated RBC to bEND3
cells, increased in a concentration and time dependent manner.
Maximum RBC adhesion for the 0.3 mM t-BHP concentration
was observed at 24 h and RBC adhesion plateaued at 18 h for
1 mM and 3 mM t-BHP concentrations (Figure 2A,B).
Similarly, low and medium concentrations of t-BHP
resulted in no engulfment of RBC by bEND3 cells following
3 h incubation. There was a trend toward an increase in
the engulfment of 3 mM t-BHP-treated RBC following 3 h
incubation. Engulfment of t-BHP-treated RBC also increased
in a concentration and time dependent manner with maximum
engulfment of t-BHP-treated RBC occurring following 24 h
incubation (Figure 2C). Overall, maximum adhesion and
engulfment of t-BHP-treated RBC was observed with a
concentration of 3 mM. As shown in Figure 2D, multiple 3 mM
t-BHP-treated RBC are seen engulfed (red arrows) by a single
bEND3 cell. The average number of bEND3 cells per field of view
remained unchanged with adhesion and engulfment of t-BHPRBC over the duration of the experiment (Figure 2E) for any
experimental group and viability of the PBS- and t-BHP-treated
RBC in cell culture media was > 90% at 24 h (data not shown).
DAF assay that relies on the pseudoperoxidase activity of
hemoglobin was used to confirm erythrophagocytosis (adhesion
and engulfment) observed by microscopy. There was no
significant difference in the amount of hemoglobin detected in
the bEND3 cells incubated with PBS-treated RBC compared
with control (bEND3 monolayer only). However, bEND3 cells
incubated with t-BHP-treated RBC had a significantly higher
amount of hemoglobin, an indicator of erythrophagocytosis,

Frontiers in Cellular Neuroscience | www.frontiersin.org

Transmigration of Hemoglobin Across the
bEND3 Monolayer
We developed a method to determine the passage of hemoglobin
across the bEND3 monolayer using an in vitro transwell system.
Experimental set-up for the transmigration experiment is shown
in Figure 4A. Migration of hemoglobin across the bEND3
monolayer was determined using the DAF assay as described
above. Spontaneous migration reflects the passage of hemoglobin
from PBS-RBC across the 3 µm pore size transwell in the absence
of a bEND3 monolayer. As expected, hemoglobin passage was
observed in the absence of the bEND3 monolayer. However, in
the presence of the bEND3 monolayer, the passage of hemoglobin
from PBS-RBC across the bEND3 monolayer was the same
as control (bEND3 only) indicating no passage of hemoglobin
from PBS-RBC across the monolayer. There was a significant
increase in the hemoglobin in the basolateral chamber of wells
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FIGURE 2 | Erythrophagocytosis by brain endothelial cells. Significant time- and concentration-dependent increase in adhesion (A,B) and engulfment (C) of
t-BHP-treated RBC compared with PBS-treated RBC using light microscopy. Marked time dependent increase in engulfment of t-BHP-treated RBC by bEND3 cells
indicated by red arrows (D). Brain endothelial erythrophagocytosis at 24 h was not associated with bEND3 degradation or loss (E). Significant increase in the amount
of hemoglobin retained by the bEND3 cells incubated with t-BHP-treated RBC compared with PBS-treated RBC following 24 h incubation confirming
erythrophagocytosis using the DAF colorimetric method (F). Data is presented as mean ± SEM of at least 3 independent experiments. *p < 0.05, **p < 0.01, ***p <
0.001, ****p < 0.0001. EC, endothelial cells.

DISCUSSION

incubated with t-BHP-treated RBC compared with PBS-treated
RBC confirming passage of hemoglobin from t-BHP-treated RBC
across the bEND3 monolayer (Figure 4B).
To determine if passage of hemoglobin from the t-BHPtreated RBC was associated with changes in bEND3 monolayer
integrity, we measured TEER values, before and 24 h after
RBC incubation. No changes in TEER were observed for all
concentrations of t-BHP compared with PBS-RBC used as
control, confirming that the passage of hemoglobin from tBHP-RBC was not associated with altered bEND3 monolayer
integrity (Figure 4C). Further, to rule out the possibility of
an increase in hemoglobin release with t-BHP in the apical
chamber that may result in higher hemoglobin in the basolateral
chamber, we determined the amount of free hemoglobin released
by PBS- and t-BHP-treated RBC over the course of 24 h. We
found that treating RBC with t-BHP did not increase the free
hemoglobin released in the media compared with PBS-treated
RBC (Figure 4D).

In this study we demonstrate that RBC exposed to the
oxidative stressor t-BHP undergo significant erythrophagocytosis
(adhesion and engulfment) by the brain endothelial cells
in an in vitro cell culture system. Further, this enhanced
erythrophagocytosis was associated with an increased passage
of RBC degradation product hemoglobin across the brain
endothelial cells. No change in brain endothelium monolayer
integrity was observed with passage of hemoglobin across the
endothelial monolayer in the current study. In vivo studies using
Tie2-GFP mice further verified the passage of t-BHP-treated RBC
across the brain endothelium.
Under normal physiological conditions, the adhesion of
RBC to the vascular endothelium is negligible. However,
altered RBC-vascular endothelial adhesion has been observed
in various pathological conditions including sickle cell disease
(SCD), diabetes mellitus, malaria, and retinal vein occlusion
(Wautier and Wautier, 2013). Pathological adherence of
RBC to the vascular endothelium is associated with vascular
complications including vaso-occlusive events observed
in SCD (Wautier et al., 1985). Further, cytoadherence of
plasmodium falciparum-infected RBC to the brain microvascular
endothelium has been demonstrated in cerebral malaria
(Jambou et al., 2010; El-Assaad et al., 2013; Howland
et al., 2015). Besides abnormal adhesion of RBC to the
vascular endothelium, recent studies report endothelial

Passage of RBC Across the Brain
Endothelium in vivo
In vivo studies in Tie2-GFP mice showed that PKH-26 labeled
PBS-treated RBC were confined to the cerebral vasculature.
However, PKH-26 labeled t-BHP-treated RBC were found inside,
outside, partially outside, and partially attached to the cerebral
vasculature (Figure 5).
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FIGURE 3 | Confocal microscopy of bEND3 cells and RBC to confirm erythrophagocytosis. Maximum projection of z-stack shows adhesion of t-BHP-treated RBC to
bEND3 cells and no adhesion of PBS-treated RBC (Blue = DRAQ5 stain for the endothelial nucleus, green = tight junction ZO-1 protein and autofluorescence of
RBC) (A). Orthogonal view of a single projection, maximum projection of a z-stack and individual images of a z-stack moving from top to bottom of a cover glass
confirm the internalization of t-BHP-treated RBC by bEND3 cells (B). Scale bar = 10 µm.

In the current proof-of-concept study, PS exposure to mimic
aged and/or injured RBC in vivo was triggered by treating RBC
with t-BHP (Figure 1B) which, although an exogenous agent, is
known to result in exposure of PS to the outer-leaflet of RBC
(Fens et al., 2010), and is widely used as an external inducer of
oxidative stress (Zou et al., 2001). Notably, oxidation of RBC
plays an important role in erythrophagocytic clearance of aged
and/or injured RBC (Kiefer and Snyder, 2000). As previously
demonstrated by others, we found that a large percent of the tBHP-treated RBC exposed PS (Fens et al., 2012). Consistent with
studies using peripheral endothelial cells (Fens et al., 2012), in the
current study we found that murine RBC treated with varying
concentrations of t-BHP resulted in robust adhesion followed
by engulfment of RBC by the murine brain endothelial cells
(bEND3) (Figures 2, 3), a well-characterized immortalized brain
microvascular cell line known to retain many morphological and
biochemical properties similar to in vivo conditions (Omidi et al.,
2003). Adhesion and engulfment of t-BHP-RBC was confirmed
using multiple approaches (H&E, DAF assay, confocal analysis
and live imaging). Erythrophagocytosis of t-BHP-RBC was not
associated with loss or degradation of brain endothelial cells in
the current study and is in agreement with a recent study using
HUVEC cells, in which erythrophagocytosis of oxidative stressexposed RBC did not result in immediate signs of degradation
and only a small fraction of HUVEC cells showed signs of
apoptosis after 24 h incubation (Fens et al., 2012).
Treatment of RBC with other pathological stimuli such
as LPS or neuraminidase did not result in brain endothelial

erythrophagocytosis, a phenomenon by which aged and/or
injured RBC adhere to and are engulfed by endothelial
cells of peripheral origin including HUVECs and hepatic
sinusoidal endothelial cells (Fens et al., 2010, 2012; Lee et al.,
2011).
Among the first mechanisms shown to be involved in the
phagocytic removal of aged, senescent, or injured RBC from the
blood circulation (erythrophagocytosis) is membrane scrambling
leading to the exposure of membrane PS to the outer leaflet
of the RBC membrane (Bratosin et al., 1998). PS exposure
serves as an “eat me” signal that triggers erythrophagocytosis by
phagocytes, thereby facilitating erythrocyte clearance from the
circulation (Schroit et al., 1985). Some of the seminal studies
of RBC erythrophagocytosis showed that RBC with abnormal
distribution of PS in the outer cell wall were phagocytized by
macrophages more readily than normal or healthy RBC (Bratosin
et al., 1998). PS-exposing cells are cleared from the circulation
through recognition by receptors, including scavenger receptors,
αvβ3 integrins, MerTK, TIM-1 and 4, BAI1, and Stabilin1 and
2, and subsequent attachment, cytoskeleton rearrangement and
phagolysosomal processing (Ravichandran and Lorenz, 2007).
The role of PS in endothelium-mediated erythrophagocytosis was
also recently demonstrated (Lee et al., 2011; Fens et al., 2012). In
these studies, PS-mediated endothelial erythrophagocytosis was
mediated by the αvβ3 integrins (Fens et al., 2012) or stabilin 1 and
2 (Lee et al., 2011). Apart from endothelial erythrophagocytosis,
PS exposure also plays a pivotal role in pathologic RBC adherence
to vascular endothelium (Setty et al., 2002; Wautier et al., 2011).
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FIGURE 4 | Transmigration of hemoglobin across the bEND3 monolayer. Experimental set up to detect passage of hemoglobin across the bEND3 monolayer (A).
Significant increase in the passage of hemoglobin across the bEND3 monolayer incubated with t-BHP-treated RBC compared with PBS-RBC. Spontaneous migration
reflects passage of hemoglobin from PBS-RBC across the 3 µm pore size transwell in the absence of a bEND3 monolayer (B). Passage of hemoglobin across the
bEND3 monolayer grown on transwells incubated with t-BHP-RBC was not accompanied by a change in TEER; TEER measurements are presented as % of
PBS-RBC values (C). Free hemoglobin released by t-BHP-treated RBC is significantly lower compared with PBS-treated RBC. The bEND3 monolayer was grown on
standard cell culture wells (D). Data is presented as mean ± SEM of at least 3 independent experiments. **p < 0.01, ****p < 0.0001.

erythrophagocytosis or PS exposure (data not shown) in the
current study. Further, activation of the brain endothelial cells
with LPS did not augment erythrophagocytosis of t-BHP-treated
RBC (Figure 1). These results are in contrast to previous studies
in which treatment of RBC with LPS or neuraminidase resulted
in significant adhesion to vascular endothelium (Tissot Van Patot
et al., 1996; Eichelbrönner et al., 2000; Yang et al., 2014), and
activation of endothelial cells with LPS further augmented such
RBC-endothelial cell interactions in vitro (Tissot Van Patot et al.,
1996; Eichelbrönner et al., 2000; Setty and Betal, 2008). The use
of brain microvascular endothelial cells in the current study, as
opposed to peripheral endothelial cells used in all the previous
studies, may explain this difference in outcome.
After demonstrating robust erythrophagocytosis of RBC
exposed to oxidative stress by the brain microvascular endothelial
cells in vitro, the main question we wanted to address was
whether brain endothelial erythrophagocytosis was associated
with the passage of RBC or hemoglobin (RBC degradation
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product) across the brain endothelium. In the current study,
we show significant passage of hemoglobin across the brain
endothelial monolayer incubated with t-BHP-treated RBC
(Figure 4). We further confirmed that the passage of hemoglobin
was not associated with a change in the brain endothelial
monolayer integrity since the TEER values remained unchanged
for the duration of the experiment.
To evaluate the possibility of migration of free apical
hemoglobin from t-BHP-treated RBC across the monolayer into
the basolateral chamber, we determined the free hemoglobin
released by t-BHP-RBC compared with PBS-RBC over 24 h in a
separate series of experiments using bEND3 monolayers grown
in standard cell culture plates (not transwells). We found that tBHP-treated RBC did not release more free hemoglobin into the
media compared with the PBS-RBC, and there was significantly
less free hemoglobin in the media of brain endothelial cells
incubated with t-BHP-RBC compared with PBS-RBC (Figure 4)
following 18 h and 24 h incubation. This suggests that the
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FIGURE 5 | Postmortem confocal microcopy images on mouse brains showing GFP-positive brain endothelium (green) and PKH-26-labeled RBC (red). (A, Top):
PBS-RBC remain in the blood vessels (white arrows heads). (A, Bottom): t-BHP-treated RBC are inside (white arrow head) and outside the blood vessels (yellow arrow
head), and also partially extravasated into the brain (blue arrow head). Orthogonal view showing PBS-treated RBC within the blood vessel (B, Top) and t-BHP-treated
RBC partially and completely outside the blood vessel (B, Bottom). Scale bar = 50 µm.

FIGURE 6 | Proposed role of endothelial erythrophagocytosis in cerebral microhemorrhage (pseudo-microbleeds) development. Aged and/or injured RBC adhere to
(1) and are engulfed by (2) the brain endothelium. Iron rich RBC or degradation products (e.g., hemoglobin) are translocated across the brain endothelium (3), where
they may produce signatures of CMB.

RBC across the brain endothelium of Tie2-GFP mice using
confocal microscopy (Figure 5). We reported a similar finding
of extravasation of fluorescently-labeled RBC across the brain
endothelium of Tie2-GFP mice in an inflammation-induced
mouse model of CMB (Sumbria et al., 2016). In the current study,
the blood vessel adjacent to the extravasated RBC appeared intact
with no visible rupture (Figure 5).
Erythrophagocytosis mediated by macrophages involves RBC
engulfment, endosomal processing and RBC degradation
with subsequent release of hemoglobin and heme. It
should be noted that not all engulfed RBC are subjected to

hemoglobin in the basolateral chamber does not represent the
migration of free hemoglobin released in the apical chamber. The
decrease in free hemoglobin with t-BHP-RBC at 18 h and 24 h
is consistent with increased RBC erythrophagocytosis of t-BHPRBC by brain endothelial cells, and thus lower free RBC available
to release hemoglobin at these time points.
A limitation of our in vitro findings is the use of an
immortalized brain endothelial cell line. Note, however, that
passage of RBC degradation product (hemoglobin) across the
brain endothelial monolayer were corroborated by our in vivo
findings of extravasation of fluorescently-labeled t-BHP-treated

Frontiers in Cellular Neuroscience | www.frontiersin.org

9

September 2018 | Volume 12 | Article 279

Chang et al.

Brain Endothelial Erythrophagocytosis and Cerebral Microbleeds

phagosomal degradation and that the fate of the engulfed
RBC depends on the molecular machinery involved in
erythrophagocytosis (Santarino et al., 2017). The intracellular
mechanisms involved in the cellular trafficking of engulfed
RBC and subsequent RBC processing by endothelial cells are
understudied.
In the current study, we report the passage of RBC
degradation product hemoglobin in vitro and the passage of
fluorescently-labeled RBC across the brain endothelium in vivo.
The possibility of passage of RBC fragments and not intact RBC
cannot be ruled-out from the current data. We are unaware of
prior reports of extravasation of non-parasitized RBC across the
brain endothelium. Our findings are similar to the work done
by Grutzendler and co-workers who reported engulfment and
subsequent extravasation of emboli into the brain (termed as
angiophagy; Grutzendler et al., 2014). Following passage across
the brain endothelium, emboli were engulfed and degraded by
pericytes and microglial cells. Future in vitro studies using cocultures with pericytes and microglial cells will help elucidate the
intracellular trafficking and the fate of the RBC involved in brain
endothelial erythrophagocytosis.
The phenomenon of passage of intact RBC or RBC
degradation products across an intact endothelial monolayer
following endothelial erythrophagocytosis is a novel finding,
and brain endothelial erythrophagocytosis is particularly relevant
from the standpoint of non-hemorrhagic mechanisms involved
in CMB development (Figure 6) (Fisher, 2014). This is because
CMB are focal deposits of blood degradation products,
predominately hemosiderin, which is derived from hemoglobin
following hemolysis (Janaway et al., 2014). MRI detection of
CMB relies on the paramagnetic properties of hemosiderin
and any passage of hemoglobin across the brain endothelium
into the perivascular space can thus produce signatures of
CMB. Further investigation is required to determine whether
brain endothelial erythrophagocytosis and subsequent passage
of RBC or RBC degradation products across the brain
endothelium occur under physiologically relevant conditions
that induce oxidative stress in vivo to produce CMB signatures.
Notably, PS exposure on erythrocytes and oxidative stress has
been reported under several risk factors for CMB, such as
chronic kidney disease (Bonomini et al., 1999, 2002; Tucker
et al., 2015) and Alzheimer’s disease (Nicolay et al., 2007;
Gella and Durany, 2009). Further, CMB in the absence
of gadolinium extravasation (marker of blood-brain barrier
disruption) have been reported in patients with cerebral malaria
(Potchen et al., 2018), and recent work showed engulfment
of parasitized RBC by human brain endothelial cells in an in
vitro model of cerebral malaria (Jambou et al., 2010), raising
the possibility of erythrophagocytosis-dependent CMB in this
disorder.

In conclusion, we show that brain endothelial cells express
an erythrophagocytic phenotype for RBC exposed to oxidative
stress in vitro. Further, brain endothelial erythrophagocytosis
is associated with passage of hemoglobin across the brain
endothelial monolayer in vitro, and passage of RBC exposed
to oxidative stress across the brain endothelium in vivo. These
results may have significant implications for mechanisms of CMB
in the absence of frank vascular disruption.
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